Literature DB >> 20428290

Complications of pelvic lymphadenectomy: do the risks outweigh the benefits?

Stacy Loeb1, Alan W Partin, Edward M Schaeffer.   

Abstract

The American Urological Association Best Practice Policy states that although pelvic lymph node dissection (PLND) is commonly done with radical prostatectomy, its morbidity must be considered, particularly in cases in which it offers little additional information. The benefits of PLND include more accurate staging and reassurance for the patient. In addition, PLND may be therapeutic for men with lymph node metastases and may result in long-term biochemical cure for selected node-positive patients. However, the incidence of node positivity is declining, and accordingly a greater number of lymphadenectomies must be performed to benefit 1 patient. In addition to the associated cost, PLND has the potential for morbidity, including lymphoceles, thromboembolic events, ureteral injury, and neurovascular injury. Patients and physicians should therefore assess the risk/benefit ratio associated with PLND on an individual basis to permit informed treatment decisions.

Entities:  

Keywords:  Lymph node metastases; Lymphocele; Nerve injury; Pelvic lymph node dissection; Prostate cancer; Radical prostatectomy; Risk to benefit ratio; Thromboembolic events; Ureteral injury; Vascular injury

Year:  2010        PMID: 20428290      PMCID: PMC2859138     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  26 in total

1.  Lymphocyst: ultrasound diagnosis and urologic management.

Authors:  G T Basinger; R F Gittes
Journal:  J Urol       Date:  1975-11       Impact factor: 7.450

2.  How many lymphadenectomies does it take to cure one patient?

Authors:  Eric A Klein; Michael Kattan; Andrew Stephenson; Andrew Vickers
Journal:  Eur Urol       Date:  2007-09-19       Impact factor: 20.096

3.  Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.

Authors:  Christopher J Weight; Alwyn M Reuther; Paul W Gunn; Craig R Zippe; Nivedita B Dhar; Eric A Klein
Journal:  Urology       Date:  2008-01       Impact factor: 2.649

4.  Ultrasonic evaluation of lymphocele formation after staging lymphadenectomy for prostatic carcinoma.

Authors:  D B Spring; D Schroeder; S Babu; R Agee; G A Gooding
Journal:  Radiology       Date:  1981-11       Impact factor: 11.105

5.  Lymphocele after pelvic lymphadenectomy for urologic cancer.

Authors:  P C Sogani; R C Watson; W F Whitmore
Journal:  Urology       Date:  1981-01       Impact factor: 2.649

6.  Open pelvic lymph node dissection for prostate cancer: a reassessment.

Authors:  S C Campbell; E A Klein; H S Levin; M R Piedmonte
Journal:  Urology       Date:  1995-09       Impact factor: 2.649

7.  The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer.

Authors:  J E Fowler; W F Whitmore
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

8.  The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.

Authors:  Agostino Mattei; Frank G Fuechsel; Nivedita Bhatta Dhar; Sebastian H Warncke; George N Thalmann; Thomas Krause; Urs E Studer
Journal:  Eur Urol       Date:  2007-08-03       Impact factor: 20.096

9.  Effect of mini-dose heparin on lymphocele formation following extraperitoneal pelvic lymphadenectomy.

Authors:  W J Catalona; D Kadmon; D B Crane
Journal:  J Urol       Date:  1980-06       Impact factor: 7.450

10.  Complications of laparoscopic pelvic lymph node dissection.

Authors:  L R Kavoussi; E Sosa; P Chandhoke; G Chodak; R V Clayman; H R Hadley; K R Loughlin; H C Ruckle; D Rukstalis; W Schuessler
Journal:  J Urol       Date:  1993-02       Impact factor: 7.450

View more
  14 in total

Review 1.  Reducing morbidity of pelvic and retroperitoneal lymphadenectomy.

Authors:  Mark W Ball; Michael A Gorin; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  Delayed bilateral obturator nerve injury due to compressing bilateral pelvic lymphoceles after robot-assisted laparoscopic radical prostatectomy and bilateral lymphadenectomy for prostatic carcinoma.

Authors:  Ayman Aljomaa
Journal:  Avicenna J Med       Date:  2018 Jul-Sep

Review 3.  Complications of pelvic lymph node dissection for prostate cancer.

Authors:  K A Keegan; M S Cookson
Journal:  Curr Urol Rep       Date:  2011-06       Impact factor: 3.092

4.  Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse.

Authors:  Andreas Hiester; Alessandro Nini; Günter Niegisch; Christian Arsov; Hubertus Hautzel; Christina Antke; Lars Schimmöller; Peter Albers; Robert Rabenalt
Journal:  World J Urol       Date:  2019-01-14       Impact factor: 4.226

Review 5.  PET imaging for lymph node dissection in prostate cancer.

Authors:  Elena Incerti; Paola Mapelli; Luigi Gianolli; Maria Picchio
Journal:  World J Urol       Date:  2016-10-17       Impact factor: 4.226

6.  Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device.

Authors:  Naotake Tsuda; Kimio Ushijima; Kouichiro Kawano; Shuji Takemoto; Shin Nishio; Gounosuke Sonoda; Toshiharu Kamura
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401

7.  Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol.

Authors:  Oscar A Debats; Ansje S Fortuin; Hanneke J M Meijer; Thomas Hambrock; Geert J S Litjens; Jelle O Barentsz; Henkjan J Huisman
Journal:  PeerJ       Date:  2016-10-20       Impact factor: 2.984

8.  Predictive Nomogram and Risk Factors for Lymph Node Metastasis in Bladder Cancer.

Authors:  Zijian Tian; Lingfeng Meng; Xin Wang; Tongxiang Diao; Maolin Hu; Miao Wang; Yaqun Zhang; Ming Liu
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

9.  Trial of ligation versus coagulation of lymphatics in dynamic inguinal sentinel lymph node biopsy for staging of squamous cell carcinoma of the penis.

Authors:  S La-Touche; B Ayres; W Lam; H M Alnajjar; M Perry; N Watkin
Journal:  Ann R Coll Surg Engl       Date:  2012-07       Impact factor: 1.891

10.  Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer.

Authors:  Narges Zamani; Mitra Modares Gilani; Fateme Zamani; M Hossein Zamani
Journal:  J Family Reprod Health       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.